| Product Code: ETC13296580 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Cannabis Pharmaceuticals Market was valued at USD 7.1 Billion in 2024 and is expected to reach USD 15.4 Billion by 2031, growing at a compound annual growth rate of 10.35% during the forecast period (2025-2031).
The Global Cannabis Pharmaceuticals Market is experiencing significant growth driven by increasing legalization of medical marijuana, growing acceptance of cannabis-based products for various medical conditions, and ongoing research and development efforts. The market is characterized by a wide range of products including oils, tinctures, capsules, and topical creams infused with cannabinoids such as CBD and THC. Key players in the market are expanding their product portfolios through strategic partnerships, acquisitions, and investments in advanced technologies. North America is currently the largest market for cannabis pharmaceuticals, followed by Europe and Asia Pacific. Factors such as changing regulatory landscapes, shifting consumer preferences towards natural remedies, and the potential therapeutic benefits of cannabis compounds are expected to further propel market growth in the coming years.
The Global Cannabis Pharmaceuticals Market is experiencing significant growth due to the increasing acceptance of medical cannabis and the legalization of cannabis for medicinal purposes in various countries. Key trends include the development of innovative cannabis-based pharmaceuticals for conditions such as chronic pain, epilepsy, and cancer, as well as the expansion of research into the therapeutic potential of cannabinoids. Opportunities in the market include the potential for new drug approvals, partnerships between pharmaceutical companies and cannabis producers, and the growing demand for alternative treatment options among patients. With the evolving regulatory landscape and shifting perceptions towards cannabis, the Global Cannabis Pharmaceuticals Market is poised for continued growth and innovation in the coming years.
The Global Cannabis Pharmaceuticals Market faces several challenges, including regulatory hurdles due to the complex and evolving legal landscape surrounding cannabis products in different countries. Additionally, there is a lack of standardized dosing and delivery methods for cannabis-based medications, leading to inconsistencies in treatment outcomes and efficacy. Quality control and product safety concerns also pose challenges, as the industry strives to establish rigorous testing protocols and standards. Limited scientific research and clinical trials on the efficacy and safety of cannabis-based pharmaceuticals further hinder market growth and acceptance by healthcare professionals and patients. Overall, navigating these challenges requires collaboration between industry stakeholders, regulators, and healthcare providers to ensure the development of safe, effective, and reliable cannabis pharmaceutical products.
The Global Cannabis Pharmaceuticals Market is primarily driven by increasing legalization of medical marijuana and growing acceptance of cannabis-based products for medical purposes. Rising awareness about the potential therapeutic benefits of cannabis in treating various medical conditions such as chronic pain, epilepsy, cancer, and multiple sclerosis is also fueling market growth. Additionally, the expanding research and development activities focused on exploring the medical applications of cannabis compounds like CBD and THC are driving innovation in the industry. The shifting regulatory landscape towards the legalization of cannabis for medical use in several countries, coupled with the growing investment in the cannabis pharmaceutical sector, are further propelling market expansion. Overall, the increasing demand for alternative treatment options and the potential of cannabis-based medicines to address unmet medical needs are key factors contributing to the growth of the Global Cannabis Pharmaceuticals Market.
Government policies related to the Global Cannabis Pharmaceuticals Market vary significantly across different countries. While some countries have legalized medical cannabis and allow for the production and sale of cannabis-based pharmaceuticals under strict regulations, others have strict laws prohibiting any form of cannabis use. In countries where medical cannabis is legal, government policies typically outline licensing requirements, quality control standards, patient eligibility criteria, and restrictions on marketing and distribution. Additionally, some governments have established frameworks for research and clinical trials to further explore the potential therapeutic benefits of cannabis-based medicines. Overall, the regulatory landscape for cannabis pharmaceuticals is evolving rapidly as more countries recognize the medical potential of cannabis and adjust their policies accordingly to ensure patient safety and promote further research and development in this emerging market.
The Global Cannabis Pharmaceuticals Market is poised for significant growth in the coming years, driven by increasing legalization of medical cannabis, growing acceptance of its therapeutic benefits, and expanding research on cannabinoids. The market is expected to witness a surge in demand for cannabis-based pharmaceutical products to treat various medical conditions such as chronic pain, epilepsy, multiple sclerosis, and cancer. With ongoing clinical trials and regulatory approvals paving the way for new product developments, the market is projected to experience substantial expansion across regions. Factors such as changing consumer preferences towards natural remedies, combined with advancements in extraction techniques and formulation technologies, are likely to fuel innovation and drive market growth. Overall, the Global Cannabis Pharmaceuticals Market shows promising prospects for robust growth and adoption in the foreseeable future.
In the global cannabis pharmaceuticals market, Asia is anticipated to witness significant growth due to increasing acceptance of medical cannabis in countries like Thailand and South Korea. North America is the largest market, driven by the legalization of cannabis for medical and recreational use in several states and Canada. In Europe, the market is growing as more countries are legalizing medical cannabis and increasing research activities. The Middle East and Africa region is expected to experience moderate growth due to evolving regulatory frameworks and growing awareness about the potential benefits of cannabis-based medicines. Latin America is also emerging as a key market with countries like Colombia and Uruguay leading the way in cannabis cultivation and export. Overall, the global cannabis pharmaceuticals market shows promising growth opportunities across different regions.
Global Cannabis Pharmaceuticals Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Cannabis Pharmaceuticals Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Cannabis Pharmaceuticals Market Revenues & Volume, 2021 & 2031F |
3.3 Global Cannabis Pharmaceuticals Market - Industry Life Cycle |
3.4 Global Cannabis Pharmaceuticals Market - Porter's Five Forces |
3.5 Global Cannabis Pharmaceuticals Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Cannabis Pharmaceuticals Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Cannabis Pharmaceuticals Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Cannabis Pharmaceuticals Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Global Cannabis Pharmaceuticals Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.10 Global Cannabis Pharmaceuticals Market Revenues & Volume Share, By Benefit, 2021 & 2031F |
4 Global Cannabis Pharmaceuticals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Cannabis Pharmaceuticals Market Trends |
6 Global Cannabis Pharmaceuticals Market, 2021 - 2031 |
6.1 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Capsules, 2021 - 2031 |
6.1.3 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Oils, 2021 - 2031 |
6.1.4 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Topicals, 2021 - 2031 |
6.2 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Pain Management, 2021 - 2031 |
6.2.3 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Anxiety Relief, 2021 - 2031 |
6.2.4 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Skin Conditions, 2021 - 2031 |
6.3 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Patients, 2021 - 2031 |
6.3.3 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.4 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Source, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Cannabis-Based, 2021 - 2031 |
6.4.3 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Hemp-Based, 2021 - 2031 |
6.4.4 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Plant-Based, 2021 - 2031 |
6.5 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Benefit, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Non-Psychoactive, 2021 - 2031 |
6.5.3 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Natural, 2021 - 2031 |
6.5.4 Global Cannabis Pharmaceuticals Market, Revenues & Volume, By Anti-Inflammatory, 2021 - 2031 |
7 North America Cannabis Pharmaceuticals Market, Overview & Analysis |
7.1 North America Cannabis Pharmaceuticals Market Revenues & Volume, 2021 - 2031 |
7.2 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Source, 2021 - 2031 |
7.7 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Benefit, 2021 - 2031 |
8 Latin America (LATAM) Cannabis Pharmaceuticals Market, Overview & Analysis |
8.1 Latin America (LATAM) Cannabis Pharmaceuticals Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Cannabis Pharmaceuticals Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Cannabis Pharmaceuticals Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Cannabis Pharmaceuticals Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Cannabis Pharmaceuticals Market, Revenues & Volume, By End User, 2021 - 2031 |
8.6 Latin America (LATAM) Cannabis Pharmaceuticals Market, Revenues & Volume, By Source, 2021 - 2031 |
8.7 Latin America (LATAM) Cannabis Pharmaceuticals Market, Revenues & Volume, By Benefit, 2021 - 2031 |
9 Asia Cannabis Pharmaceuticals Market, Overview & Analysis |
9.1 Asia Cannabis Pharmaceuticals Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Cannabis Pharmaceuticals Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Cannabis Pharmaceuticals Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Cannabis Pharmaceuticals Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Cannabis Pharmaceuticals Market, Revenues & Volume, By End User, 2021 - 2031 |
9.6 Asia Cannabis Pharmaceuticals Market, Revenues & Volume, By Source, 2021 - 2031 |
9.7 Asia Cannabis Pharmaceuticals Market, Revenues & Volume, By Benefit, 2021 - 2031 |
10 Africa Cannabis Pharmaceuticals Market, Overview & Analysis |
10.1 Africa Cannabis Pharmaceuticals Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Cannabis Pharmaceuticals Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Cannabis Pharmaceuticals Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Cannabis Pharmaceuticals Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Cannabis Pharmaceuticals Market, Revenues & Volume, By End User, 2021 - 2031 |
10.6 Africa Cannabis Pharmaceuticals Market, Revenues & Volume, By Source, 2021 - 2031 |
10.7 Africa Cannabis Pharmaceuticals Market, Revenues & Volume, By Benefit, 2021 - 2031 |
11 Europe Cannabis Pharmaceuticals Market, Overview & Analysis |
11.1 Europe Cannabis Pharmaceuticals Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Cannabis Pharmaceuticals Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Cannabis Pharmaceuticals Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Cannabis Pharmaceuticals Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Cannabis Pharmaceuticals Market, Revenues & Volume, By End User, 2021 - 2031 |
11.6 Europe Cannabis Pharmaceuticals Market, Revenues & Volume, By Source, 2021 - 2031 |
11.7 Europe Cannabis Pharmaceuticals Market, Revenues & Volume, By Benefit, 2021 - 2031 |
12 Middle East Cannabis Pharmaceuticals Market, Overview & Analysis |
12.1 Middle East Cannabis Pharmaceuticals Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Cannabis Pharmaceuticals Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Cannabis Pharmaceuticals Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Cannabis Pharmaceuticals Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Cannabis Pharmaceuticals Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Cannabis Pharmaceuticals Market, Revenues & Volume, By End User, 2021 - 2031 |
12.6 Middle East Cannabis Pharmaceuticals Market, Revenues & Volume, By Source, 2021 - 2031 |
12.7 Middle East Cannabis Pharmaceuticals Market, Revenues & Volume, By Benefit, 2021 - 2031 |
13 Global Cannabis Pharmaceuticals Market Key Performance Indicators |
14 Global Cannabis Pharmaceuticals Market - Export/Import By Countries Assessment |
15 Global Cannabis Pharmaceuticals Market - Opportunity Assessment |
15.1 Global Cannabis Pharmaceuticals Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Cannabis Pharmaceuticals Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Cannabis Pharmaceuticals Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Cannabis Pharmaceuticals Market Opportunity Assessment, By End User, 2021 & 2031F |
15.5 Global Cannabis Pharmaceuticals Market Opportunity Assessment, By Source, 2021 & 2031F |
15.6 Global Cannabis Pharmaceuticals Market Opportunity Assessment, By Benefit, 2021 & 2031F |
16 Global Cannabis Pharmaceuticals Market - Competitive Landscape |
16.1 Global Cannabis Pharmaceuticals Market Revenue Share, By Companies, 2024 |
16.2 Global Cannabis Pharmaceuticals Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |